+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ceftriaxone"

Cephalosporin Drugs - Global Strategic Business Report - Product Thumbnail Image

Cephalosporin Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 398 Pages
  • Global
From
Cephalosporin Market Report 2025 - Product Thumbnail Image

Cephalosporin Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Urinary Tract Infection Treatment Market Report 2025 - Product Thumbnail Image

Urinary Tract Infection Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Antibacterial Drugs Market Report 2024-2034 - Product Thumbnail Image

Antibacterial Drugs Market Report 2024-2034

  • Report
  • January 2024
  • 269 Pages
  • Global
From
Research Report on China's Ceftriaxone Export 2023-2032 - Product Thumbnail Image

Research Report on China's Ceftriaxone Export 2023-2032

  • Report
  • January 2023
  • 50 Pages
  • China
From
Cephalosporin Markets in China - Product Thumbnail Image

Cephalosporin Markets in China

  • Report
  • October 2024
  • 270 Pages
  • China
From
Cephalosporin Industry Forecasts - China Focus - Product Thumbnail Image

Cephalosporin Industry Forecasts - China Focus

  • Report
  • October 2024
  • 135 Pages
  • China
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Ceftriaxone is an antibiotic used to treat a wide range of bacterial infections. It belongs to the cephalosporin class of antibiotics, which are used to treat infections caused by Gram-positive and Gram-negative bacteria. Ceftriaxone is commonly used to treat infections of the respiratory tract, urinary tract, skin, and soft tissue. It is also used to treat meningitis, sepsis, and gonorrhea. Ceftriaxone is available in both intravenous and intramuscular forms, and is often used in combination with other antibiotics. The ceftriaxone market is driven by the increasing prevalence of bacterial infections, the growing demand for antibiotics, and the increasing availability of generic versions of the drug. The market is also driven by the increasing use of ceftriaxone in the treatment of multi-drug resistant infections. Some of the major companies in the ceftriaxone market include Pfizer, Merck, GlaxoSmithKline, Sanofi, Novartis, and AstraZeneca. Show Less Read more